Intravenous immunoglobulin in two children with Guillain-Barré syndrome

L D Notarangelo; M Duse; S Tiberti; B Guarneri; A Brunori; A Negrini; A G Ugazio

doi:10.1007/BF01956757

Intravenous immunoglobulin in two children with Guillain-Barré syndrome

Eur J Pediatr. 1993 Apr;152(4):372-4. doi: 10.1007/BF01956757.

Authors

L D Notarangelo¹, M Duse, S Tiberti, B Guarneri, A Brunori, A Negrini, A G Ugazio

Affiliation

¹ Department of Paediatrics, University of Brescia, Italy.

PMID: 8482293
DOI: 10.1007/BF01956757

Abstract

Two children with Guillain-Barrè syndrome were successfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.

Publication types

Case Reports

MeSH terms

Adolescent
Child
Female
Humans
Immunoglobulins, Intravenous / therapeutic use*
Male
Polyradiculoneuropathy / therapy*
Recurrence

Substances

Immunoglobulins, Intravenous